Mitigating the SARS-CoV-2 Delta disease burden in Australia by non-pharmaceutical interventions and vaccinating children: a modelling analysis

Table 4 Hospitalisations per million for increasing vaccination coverage levels (ages 12 and up, and 5 and up), with and without moderate NPIs. Vaccine with 88% efficacy assumed for all ages. R₀ of=6.0. Median value of 100 simulations presented

Hospitalisations		Total	0–12 years	13–24 years	25–44 years	45–64 years	65–79 years	80 years+
No NPIs	70% 12+	1585	65	46	298	426	355	394
	70% 5+	1522	39	46	291	417	346	383
	80% 12+	1095	62	33	213	295	234	259
	80% 5+	996	32	31	199	279	217	238
	90% 12+	616	57	18	125	163	121	132
	90% 5+	440	20	15	94	125	89	97
Moderate NPIs	70% 12+	1073	58	38	240	319	206	213
	70% 5+	940	30	35	213	290	183	189
	80% 12+	611	50	22	143	179	106	110
	80% 5+	382	17	15	93	121	68	68
	90% 12+	260	41	8	63	70	39	39
	90% 5+	1	0	0	0	0	0	0

ISSN: 1741-7015